Labcorp forms strategic partnership with md anderson cancer center foundation spain to increase access to early phase oncology clinical trials

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced it has formed a strategic partnership with md anderson cancer center foundation spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials. through this collaboration, oncology clinical trials managed by labcorp drug development will be prioritized and conducted at md anderson cancer center foundation spain
LH Ratings Summary
LH Quant Ranking